Insider · CIK 0001222247

BLUM LEONARD M

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001222247

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-05-14	EYPTEyePoint, Inc. · Employee Stock Option (right to buy)A Award	See Remarks	AAward	+65K sh	—	—	65,000
2018-05-14	EYPTEyePoint, Inc. · Employee Stock Option (right to buy)A Award	See Remarks	AAward	+375K sh	—	—	375,000
2016-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−16.1K sh	$15.65	−$252K	182,731
2015-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−934 sh	$12.98	−$12.1K	198,832
2015-06-02	TBPHTheravance Biopharma, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−7,360 sh	$13.83	−$102K	199,766
2015-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−673 sh	$14.24	−$9,583.52	207,126
2015-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−674 sh	$19.52	−$13.2K	207,799
2015-02-05	TBPHTheravance Biopharma, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+90K sh	—	—	208,473
2014-10-08	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Sr VP, Chief Comm. Officer	AAward	+170K sh	—	—	170,000
2014-08-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−3,261 sh	$22.76	−$74.2K	401,538
2014-02-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−4,311 sh	$39.98	−$172K	286,783
2013-07-24	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+5,000 sh	—	—	291,094
2013-05-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−3,292 sh	$37.01	−$122K	286,094
2013-02-07	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+5,000 sh	—	—	289,386
2012-10-15	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+5,000 sh	—	—	284,386
2012-07-30	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−7,546 sh	$29.69	−$224K	279,386
2012-02-15	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+5,000 sh	—	—	286,932
2011-02-11	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+100K sh	—	—	281,932
2011-02-11	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+12.5K sh	—	—	181,932
2010-10-26	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+12.5K sh	—	—	169,432
2010-05-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−1,686 sh	$13.02	−$22K	156,932
2010-02-25	INVAInnoviva, Inc.P Purchase	Sr VP, Chief Comm. Officer	PPurchase	+677 sh	$10.33	+$6,993.41	158,618
2010-02-24	INVAInnoviva, Inc.P Purchase	Sr VP, Chief Comm. Officer	PPurchase	+12K sh	$10.48	+$126K	157,941
2010-02-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−1,335 sh	$10.22	−$13.6K	145,916
2010-02-10	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+25K sh	—	—	147,251
2009-11-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−1,114 sh	$14.04	−$15.6K	122,251
2009-08-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−1,084 sh	$15.65	−$17K	123,365
2009-05-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−1,086 sh	$14.06	−$15.3K	124,449
2009-03-20	INVAInnoviva, Inc.A Award	Sr VP, Chief Comm. Officer	AAward	+35K sh	—	—	125,535
2009-02-20	INVAInnoviva, Inc.F Tax Payment	Sr VP, Chief Comm. Officer	FTax Payment	−1,461 sh	$14.87	−$21.7K	90,535
2008-07-23	INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award	Sr VP, Chief Comm. Officer	AAward	+30K sh	—	—	30,000
2008-03-10	INVAInnoviva, Inc.P Purchase	Sr VP, Chief Comm. Officer	PPurchase	+2,385 sh	$9.97	+$23.8K	91,996
2008-03-10	INVAInnoviva, Inc.P Purchase	Sr VP, Chief Comm. Officer	PPurchase	+26K sh	$10.92	+$284K	89,611
2007-01-29	ICOS CORPStock Option (right to buy)D Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−114K sh	$4.27	−$485K	0
2007-01-29	ICOS CORPStock Option (right to buy)D Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−50K sh	$9.11	−$456K	0
2007-01-29	ICOS CORPStock Option (right to buy)D Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−25K sh	$11.14	−$279K	0
2007-01-29	ICOS CORPStock Option (right to buy)D Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−50K sh	$8.62	−$431K	0
2007-01-29	ICOS CORPD Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−85.8K sh	$34.00	−$2.92M	0
2007-01-29	ICOS CORPD Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−2,500 sh	$34.00	−$85K	0
2007-01-29	ICOS CORPD Disposition to Issuer	Senior VP, Sales and Marketing	DDisposition to Issuer	−4,300 sh	$34.00	−$146K	0
2006-06-13	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+2,000 sh	$22.31	+$44.6K	2,500
2006-06-13	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+6,000 sh	$22.29	+$134K	86,400
2005-12-29	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+1,000 sh	$27.97	+$28K	73,400
2005-07-19	ICOS CORPA Award	Senior VP, Sales and Marketing	AAward	+55K sh	—	—	72,400
2005-01-27	ICOS CORPCommon Stock (Right to Buy)A Award	Senior VP, Sales and Marketing	AAward	+50K sh	—	—	50,000
2004-02-11	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+800 sh	$40.15	+$32.1K	15,300
2004-02-11	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+100 sh	$40.14	+$4,014	15,400
2004-02-11	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+100 sh	$40.11	+$4,011	15,500
2004-02-11	ICOS CORPP Purchase	Senior VP, Sales and Marketing	PPurchase	+500 sh	$40.17	+$20.1K	500
2004-01-21	ICOS CORPStock Option (Right to Buy)A Award	Senior VP, Sales and Marketing	AAward	+33.5K sh	—	—	33,500

Recent filings

Accepted (ET)
May 164
BLUM LEONARD M0000899243-18-013140
SEC(opens sec.gov)
Feb 234
Theravance Biopharma, Inc.0001179110-16-019957
SEC(opens sec.gov)
Aug 244
Theravance Biopharma, Inc.0001179110-15-012564
SEC(opens sec.gov)
Jun 44
Theravance Biopharma, Inc.0001179110-15-009218
SEC(opens sec.gov)
May 224
Theravance Biopharma, Inc.0001179110-15-008526
SEC(opens sec.gov)
Feb 244
Theravance Biopharma, Inc.0001179110-15-003382
SEC(opens sec.gov)
Feb 94
Theravance Biopharma, Inc.0001179110-15-002168
SEC(opens sec.gov)
Oct 104
Theravance Biopharma, Inc.0001179110-14-015387
SEC(opens sec.gov)
Aug 224
THERAVANCE INC0001179110-14-013186
SEC(opens sec.gov)
Feb 244
THERAVANCE INC0001179110-14-003521
SEC(opens sec.gov)
Jul 264
THERAVANCE INC0001179110-13-012216
SEC(opens sec.gov)
May 224
BLUM LEONARD M0001179110-13-008886
SEC(opens sec.gov)
Feb 114
BLUM LEONARD M0001179110-13-002419
SEC(opens sec.gov)
Oct 174
BLUM LEONARD M0001179110-12-015262
SEC(opens sec.gov)
Aug 14
BLUM LEONARD M0001179110-12-012204
SEC(opens sec.gov)
Feb 174
BLUM LEONARD M0001179110-12-003023
SEC(opens sec.gov)
Feb 154
BLUM LEONARD M0001179110-11-002794
SEC(opens sec.gov)
Oct 284
BLUM LEONARD M0001179110-10-015347
SEC(opens sec.gov)

Companies

Address

THERAVANCE, INC. 901 GATEWAY BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080